A new medicinal cannabis brand for expanding the Special Access Scheme market

Wellnex Life Limited (ASX: WNX) has recently introduced a new brand of medicinal cannabis, Wellness Life, through a collaborative effort with Onelife Botanicals. The brand provides a variety of products that are recommended by healthcare professionals and distributed through Australian pharmacies. Recently, it acquired the Australian topical pain relief brand Pain Away, enhancing its product portfolio and driving financial growth, solidifying its position as a critical player in the healthcare sector domestically and internationally.

Customers can order the brand through The Entourage Effect, a prominent distributor of medicinal cannabis in Australia. Furthermore, the Entourage Effect appointed Dr. Mihindu Jayasuriya and Dr. Tony Farag as senior medical advisors to ensure they provide training and education in prescribing Wellness Life products.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com